| Thrombophilic screening in young patients (<40years) with idiopathic ischemic stroke: A controlled study. | |
| | |
MedLine Citation:
|
PMID: 21172722 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
INTRODUCTION: Despite extensive clinical and laboratory investigations, the etiology of ischemic stroke remains unknown in approximately one third of patients. MATERIALS AND METHODS: Thirty-four consecutive patients less than 40years old (Males 13, Females 21, mean age 26.6years, range 2-39) with documented ischemic stroke underwent, one year after the acute event, laboratory evaluation of antithrombin, protein C, free and total protein S, activated protein C resistance, fibrinogen, factor VII:C, homocysteine levels and antiphospholipid antibodies (APA). Moreover, prevalence of F5 R506Q, F2 G2021A and homozygosis for thermolabile variant C677T of the methylenetetrahydrofolate reductase (MTHFR) were also evaluated and compared to the results obtained in 120 normal controls. RESULTS: Antithrombin and protein C levels resulted normal in all cases. One patient (2.9%) showed free protein S deficiency and 3 patients (8.8%) had activated protein C resistance. Homocysteine levels above 15μmol/L were found in one patient (2.9%). APA were found in 21 patients (61.7%) and in only 2 out of 120 (1.66%) controls (OR=95.31; 95% C.I.: 18.22-667.81). The multivariate analysis selected that the presence of APA was significantly associated with an increased risk of stroke (OR=156.60; 95% C.I.: 25.99-943.47) in this cohort of patients. The combination between APA and cardiovascular risk factors determined a risk of 29-fold (OR=29.31; 95% CI: 3.28-261.69). DISCUSSION: Our data suggest that the presence of APA is associated with an increased risk of idiopathic ischemic stroke in young patients. Furthermore, also the combination of APA and cardiovascular risk factors is significantly associated with development of idiopathic ischemic stroke. |
| | |
Authors:
|
Francesco Dragoni; Flavia Chiarotti; Giuseppe Rosano; Paolo Simioni; Daniela Tormene; Maria Gabriella Mazzucconi; Arturo Cafolla; Giuseppe Avvisati |
Publication Detail:
|
Type: Journal Article Date: 2010-12-18 |
Journal Detail:
|
Title: Thrombosis research Volume: 127 ISSN: 1879-2472 ISO Abbreviation: Thromb. Res. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0326377 Medline TA: Thromb Res Country: United States |
Other Details:
|
Languages: eng Pagination: 85-90 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Thrombosis Center, Department of "Biotecnologie Cellulari ed Ematologia", University "Sapienza", Rome, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patient...
Next Document: Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from th...